New single-concentration acetaminophen products added to PediaCare, Little Remedies lines

IRVINGTON, N.Y. — Prestige Brands on Thursday announced the launch of its new PediaCare and Little Remedies single-concentration acetaminophen products.

The new standard concentration liquid acetaminophen products for infants and children under 2 years of age will be 160 mg/5 mL.

“The voluntary changes to single-concentration acetaminophen dosing demonstrate the continued commitment to accuracy, safety and innovation from PediaCare and Little Remedies," Prestige VP over-the-counter products Albert Hwang said.

Both PediaCare and Little Remedies also will offer additional product enhancements, including age-appropriate dosing devices. Infant products now will contain a special dosing syringe and flow restrictors on the bottles. Children’s products, for ages 2 to 11 years, will have the bottles with flow restrictors and will continue to contain dosing cups. Both infant and children’s formulations will continue to have weight-based instructions on the package as well.

“While the new single-concentration for PediaCare and Little Fevers infants’ and children’s acetaminophen products will be among the first brands to hit store shelves, parents should know that there will be a ’transition period’ during which the existing concentrated infant products and the new standard-strength acetaminophen infant PediaCare and Little Fevers products may be on store shelves simultaneously,” Hwang said. “The new infant formula is less concentrated, and the dose is therefore more than in the older infant formulation. And while reading and following package directions is always recommended to obtain accurate dosing instructions, it will be even more important while the two concentrations are available."

The new PediaCare and Little Remedies products will be available this month at pharmacies nationwide. To learn more about the new acetaminophen dosing system for PediaCare or Little Remedies, visit PediaCare.com or LittleRemedies.com.

Login or Register to post a comment.